349 related articles for article (PubMed ID: 11665725)
21. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
Schaller M; Sigurgeirsson B; Sarkany M
Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
[TBL] [Abstract][Full Text] [Related]
22. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
[TBL] [Abstract][Full Text] [Related]
23. A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis.
Yu B; Zhou G; Wang B; Ben Y; Yan H; Shao Y; Wang B
Chin Med Sci J; 1991 Sep; 6(3):166-8. PubMed ID: 1838936
[TBL] [Abstract][Full Text] [Related]
24. Development of ciclopirox nail lacquer with enhanced permeation and retention.
Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F
J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447
[TBL] [Abstract][Full Text] [Related]
26. Management of onychomycosis with topicals.
Albert SF; Weis ZH
Clin Podiatr Med Surg; 2004 Oct; 21(4):605-15, vii. PubMed ID: 15450900
[TBL] [Abstract][Full Text] [Related]
27. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
Avner S; Nir N; Henri T
J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
[TBL] [Abstract][Full Text] [Related]
28. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
Pollak RA
J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
[TBL] [Abstract][Full Text] [Related]
29. The use of topical therapies to treat onychomycosis.
Gupta AK; Ryder JE; Baran R
Dermatol Clin; 2003 Jul; 21(3):481-9. PubMed ID: 12956200
[TBL] [Abstract][Full Text] [Related]
30. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
Gupta AK
J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408
[TBL] [Abstract][Full Text] [Related]
31. Congenital candidal onychomycoses: effective cure with ciclopirox olamine 8% nail lacquer.
Sardana K; Garg VK; Manchanda V; Rajpal M
Br J Dermatol; 2006 Mar; 154(3):573-5. PubMed ID: 16445808
[No Abstract] [Full Text] [Related]
32. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis.
Baran R; Tosti A; Hartmane I; Altmeyer P; Hercogova J; Koudelkova V; Ruzicka T; Combemale P; Mikazans I
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):773-81. PubMed ID: 19453778
[TBL] [Abstract][Full Text] [Related]
33. Treatment costs of three nail lacquers used in onychomycosis.
Marty JP; Lambert J; Jäckel A; Adjadj L
J Dermatolog Treat; 2005; 16(5-6):299-307. PubMed ID: 16428149
[TBL] [Abstract][Full Text] [Related]
34. Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
Tosti A
Cutis; 2013 Oct; 92(4):203-8. PubMed ID: 24195094
[TBL] [Abstract][Full Text] [Related]
35. Case report: onychomycosis due to Trichophyton schoenleinii.
Macura AB; Krzyściak P; Skóra M; Gniadek A
Mycoses; 2012 Mar; 55(2):e18-9. PubMed ID: 21771109
[No Abstract] [Full Text] [Related]
36. Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
Rosen T; Stein Gold LF
Semin Cutan Med Surg; 2016 Mar; 35(3 Suppl 3):S51-5. PubMed ID: 27074700
[TBL] [Abstract][Full Text] [Related]
37. Onychomycosis due to Microsporum gypseum.
Romano C
Mycoses; 1998; 41(7-8):349-51. PubMed ID: 9861844
[TBL] [Abstract][Full Text] [Related]
38. Onychomycosis and AIDS: treatment with topical ciclopirox olamine.
Dompmartin D; Dompmartin A; Deluol AM; Coulaud JP
Int J Dermatol; 1990 Apr; 29(3):233. PubMed ID: 2139871
[No Abstract] [Full Text] [Related]
39. Topical treatments for onychomycosis: a historical perspective.
Bodman MA; Feder L; Nace AM
J Am Podiatr Med Assoc; 2003; 93(2):136-41. PubMed ID: 12644521
[TBL] [Abstract][Full Text] [Related]
40. Topical treatment of onychomycosis with efinaconazole solution 10%.
Rich P
Cutis; 2013 Jun; 91(6):305-7. PubMed ID: 23837154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
